Refoxy Pharma
PrivateLast Round
Seed
Dec 4, 2024
Total Funding Raised
$15.4M
Company Overview
Refoxy Pharma is a biotechnology company developing small molecule activators of the FOXO3 transcription factor for the treatment of age-related diseases, with an initial focus on idiopathic pulmonary fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Refoxy Pharma Comparables
Compare Refoxy Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Isterian Biotech | 81% | |
| Oorja Bio, Inc. | 78% | |
| Mediar Therapeutics | 71% |
Refoxy Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 4, 2024 | ||||
| Seed | Nov 30, 2022 | ||||
| Seed | Aug 1, 2021 |
Refoxy Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NRW.Venture | Seed |
| Boehringer Ingelheim | Seed |
| NRW.Bank | Seed |
| Korify Capital | Seed |
| Boehringer Ingelheim Venture Fund | Seed |
| High-Tech Gründerfonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Monthly visitors grew 300% MoM, reaching 977.
- Dec 4, 2024
$9.7M round led by Boehringer Ingelheim.
Refoxy Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Refoxy Pharma's valuation, stock price, and market status.
Is Refoxy Pharma a public or private company?
Refoxy Pharma is a private company.
What is the current stock price of Refoxy Pharma?
Refoxy Pharma is a private company, so its shares have no public market price. Caplight tracks Refoxy Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Refoxy Pharma worth (valuation)?
Valuation information for Refoxy Pharma is not publicly available.
Can I buy Refoxy Pharma stock?
Refoxy Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Refoxy Pharma's last funding round?
Refoxy Pharma's most recent funding round was Seed on December 4, 2024.
Who are the main investors in Refoxy Pharma?
Key investors in Refoxy Pharma include Boehringer Ingelheim, Boehringer Ingelheim Venture Fund.
Will Refoxy Pharma IPO soon?
No public IPO plans have been announced for Refoxy Pharma.
How can I track Refoxy Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Refoxy Pharma's shares on secondary markets.